RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma
Status:
Recruiting
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
This project proposes to establish a prospective, multicenter, randomized, controlled
clinical study to compare the safety and efficacy of Intralesional Rituximab Injection versus
Involved Site Radiation Therapy for the treatment of primary ocular adnexal MALT lymphoma.
The aim is to provide high-level clinical evidence for the treatment of ocular adnexal MALT
lymphoma and to offer patients treatment options that have fewer complications and comparable
therapeutic effects.
Phase:
N/A
Details
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University